Virax Biolabs Group Limited (VRAX) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Virax Biolabs Group Limit...

    NASDAQ: VRAX · Real-Time Price · USD
    0.62
    0.01 (1.54%)
    At close: Oct 03, 2025, 3:59 PM
    0.62
    1.40%
    After-hours: Oct 03, 2025, 06:50 PM EDT

    Virax Biolabs Income Statement

    Financials in USD. Fiscal year is April - March.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q2 2025 Q4 2024 Q2 2024 Q4 2023 Q2 2023 Q4 2022 Q2 2022 Q4 2021 Q2 2021
    Period Ending Sep 30, 2024 Mar 31, 2024 Sep 30, 2023 Mar 31, 2023 Sep 30, 2022 Mar 31, 2022 Sep 30, 2021 Mar 31, 2021 Sep 30, 2020
    Revenue
    		 4.95K 79.92K 76.5K 2.8K 5.76K -92.86K n/a 109.82K 14K
    Cost of Revenue
    		 11.43K 39.85K 65.98K 4.28K 5.64K 99.94K n/a 133.25K n/a
    Gross Profit
    		 -6.47K 40.07K 10.52K -1.48K 118.00 -192.81K n/a -23.43K 14K
    Operating Income
    		 -2.88M -3.79M -2.71M -4.29M -1.44M -1.17M -566.74K -273.08K -371.46K
    Interest Income
    		 n/a n/a 10.11K 5.86K 9.61K 1.29K 14.14K 10.51K 18.13K
    Pretax Income
    		 -2.89M -3.82M -2.91M -4M -1.45M -1.17M -575.04K -283.33K -389.58K
    Net Income
    		 -2.76M -3.82M -2.91M -4.01M -1.44M -1.16M -552.42K -307.53K -343.46K
    Selling & General & Admin
    		 2.15M 2.29M 2.31M 3.99M 1.34M 841.29K 458.64K 187.92K 326.96K
    Research & Development
    		 726.41K 1.15M 409.3K 300.49K 96.62K 325.65K 108.1K 61.72K 58.5K
    Other Expenses
    		 n/a 390.36K n/a n/a n/a 519.23K n/a n/a n/a
    Operating Expenses
    		 2.87M 3.83M 2.72M 4.29M 1.44M 1.17M 566.74K 249.65K 385.46K
    Interest Expense
    		 25.59K 16.76K 10.11K 5.86K 9.61K 1.29K 14.14K 10.51K 18.13K
    Selling & Marketing Expenses
    		 n/a 33K 33K 25.35K 51.97K 9.76K 4.06K 15.06K 42.14K
    Cost & Expenses
    		 2.88M 3.87M 2.78M 4.29M 1.45M 1.17M 566.74K 382.9K 385.46K
    Income Tax Expense
    		 -136.66K n/a -4.55K n/a n/a n/a n/a n/a n/a
    Shares Outstanding (Basic)
    		 3.1M 2.23M 1.78M 1.55M 1.17M 1.14M 1.14M 1.14M 1.14M
    Shares Outstanding (Diluted)
    		 3.1M 2.24M 1.78M 1.55M 1.17M 1.14M 1.14M 1.14M 1.14M
    EPS (Basic)
    		 -0.89 -1.71 -1.64 -2.58 -1.24 -1.02 -0.49 -0.27 -0.3
    EPS (Diluted)
    		 -0.89 -1.71 -1.64 -2.58 -1.24 -1.02 -0.49 -0.27 -0.3
    EBITDA
    		 -2.77M -3.72M -2.69M 294.07K -3.6K -1.19M 5.84K 260.00 10.00
    EBIT
    		 -2.88M -3.81M -2.71M -4M -1.44M -1.17M -560.9K -272.82K -371.45K
    Depreciation & Amortization
    		 112.09K 85.38K 17.72K 4.29M 1.44M 1.17M 566.74K 273.08K 371.46K

    Add to Watchlist